Profiles of cytokine production in recipients of transfer factors

Biotherapy

Volumn 9, Issue 1-3, 1996, Pages 55-59

  Alvarez Thull, Linda ^a   Kirkpatrick, Charles H ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

cell mediated immunity; cytokines; transfer factor

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRANSFER FACTOR; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; CELL SUSPENSION; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DONOR; DRUG MECHANISM; FEMALE; HERPES SIMPLEX VIRUS 1; HYPOTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; SENSITIZATION; SKIN INFECTION; SPLEEN CELL; SUPERNATANT; VIRUS INFECTION;

EID: 0029750483     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02628657     Document Type: Conference Paper

References (20)

1. Kirkpatrick CH: Transfer factor. J Allerg C11988; 81: 803-13.
2. Lawrence HS : Transfer factor in cellular immunity. New York: The Harvey Lectures. Series 68. Academic Press, 1974: 239.
3. Levin AS, Byers VS, Fudenberg HH, Wybran J.Hackett AJ, Johnston JO & Spitler LE. Osteogenic sarcoma: immunologie parameters before and during immunotherapy with tumorspecific transfer factor. J Clin Inv 1975; 55: 487-99.
4. Fudenberg HH & Pizza G. Transfer factor 1993: Newfrontiers. In. Progress in Drug Research 42; Jucker E. ed. Basel Switzerland: Birkhauser Verlag, 1994: 309-98.
5. Spider LE, Levin AS, Stiles DP, Fudenberg HH, Pirofsky B, August CS, Stiehm ER, Hitzig WH & Gatti RA. The WiskottAldrich sydrome: results of transfer factor therapy. J Clin Inv 1972:51:3216-24.
6. Ritts RE, Pritchard DJ, Taylor WF, Gilchrist GS & Ivins JC. Comparison of transfer factor and combination chemotherapy as post surgical adjuvants in osteogenic sarcoma: results at three years. In: Rainer H, Borberg H, Mishler JM, Schafer U, eds. Immunotherapy of Malignant Diseases. Stuttgart-New York: FK Schattauer Verlag, 1978: 343-52.
7. Pizza G, DeVinci C & Fudenberg HH. Transfer factor in malignancy. Prog Drug Res 1994; 42: 401-21.
8. Steele RW, Myers MD & Vincent MM. Transfer factorfor the prevention of varicella zoster in childhood leukemia. N Eng J Med 1980; 303: 355-59.
9. Steele RW, Heberling RL, Eichberg JW, Eller JJ, Kalter SS & Kniker WT. Prevention of herpes simplex virus type 1 fatal dissemination in primates with human transfer factor. In: Ascher MS, Gottlieb AA, Kirkpatrick CH, eds. Transfer factor: basic properties and clinical applications. New York: Academic Press, 1976: 381-86.
10. Viza D, Vich JM, Phillips J, Rosenfeld F & Davies DAL. Specific transfer factor protects mice against lethal challenge with herpes simplex virus. Cell Immun 1986; 100: 555-62.
11. Kirkpatrick CH, Rich RR & Smith TK. Effects of transfer factor on lymphocyte function in anergic patients. J Clin Inv 1972; 51:2948-58.
12. Wilson GB & Fudenberg HH. Leukocyte migration inhibition as a method for assaying transfer factor activities. Lymphokines 1981; 4: 107-73.
13. Simmons A & Nash AA. Zosteriform spread of Herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol 1984; 52: 816-21.
14. Petersen EA, Greenberg LE, Manzara T & KirkpatrickCH. Murine transfer factor. I. Description of the model and evidence for specificity. J Immunol 1981; 126: 2480-84.
15. Catanzaro A, Spitler LE & Moser KM. Immunotherapyof coccidioidomycosis. J Clin Inv 1974; 54: 690-701.
16. Manetti R, Parronchi P, Giudizi MG, Piccinni MP.Maggi E, Trinchieri G & Romagnani S. Natural killer cell stimulatory factor (Interleukin-12 PL-12]) induces T-helper type l(Thl)specific immune responses and inhibits the development of IL-producing Th ceUs. J Exp Med 1993; 177: 1199-1204.
17. Schmitt E, Hoehn P, Huels C, Goedert S, Palm N,Rude E & Germann T: T helper type l development of naive CD4+ T cells requires the coordinate action of interleukin-12 and Interferon g and is inhibited by transforming growth factor-b. Eur J Immun 1994; 24: 793-98.
18. Kobayashi M, Rtz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Shennan F, Perussia B & Trinchieri G. Identification and characterization of natural killer cell stimulatory factor(NKSF), a cytokinc with multiple biological effects on human lymphocytes. J Exp Med 1989; 170: 827-45.
19. Trinchieri G: Biology of natural killer cells.Adv. Immunol 1989; 47: 187-376.
20. Doherty PC, Allan W, Eichelberger A & Carding SR.Roles of ab and gd T cell subsets in viral immunity. Ann Rev Immunol 1992; 10: 123-51.